| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Revenue | $3.65B | +36.7% |
| Cost of Revenue | $816.0M | +11.2% |
| Gross Profit | $2.84B | +46.3% |
| R&D Expense | $997.2M | -3.1% |
| SG&A Expense | $454.5M | -13.0% |
| Operating Income | -$235.5M | +79.5% |
| Interest Expense | $46.0M | -73.6% |
| Pre-tax Income | -$265.5M | +79.9% |
| Income Tax | $12.4M | -32.2% |
| Net Income | -$277.9M | +79.3% |
| EPS (Basic) | -$1.71 | +79.4% |
| EPS (Diluted) | -$1.71 | +79.4% |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $690.6M | -51.7% |
| Short-term Investments | $1.32B | +359.7% |
| Accounts Receivable | $1.57B | +20.4% |
| Current Assets | $3.87B | +18.1% |
| Total Assets | $6.34B | +9.6% |
| Current Liabilities | $3.04B | +44.6% |
| Total Liabilities | $6.45B | +15.9% |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $449.6M | +251.1% |
| Capital Expenditures | $13.6M | +27.6% |
| Investing Cash Flow | -$1.07B | -220.6% |
| Financing Cash Flow | -$117.6M | +14.0% |
| Free Cash Flow | $436.0M | +271.5% |
| Stockholders' Equity |
| -$110.5M |
| -149.6% |